Dupilumab was more effective in the treatment of pediatric AD than methotrexate or cyclosporine, regardless of skin color or race.

Deucravacitinib treatment yields sustained improvements in joint symptoms and skin disease severity among patients with active psoriatic arthritis.

An etiology-based approach to the management of IGD should be used, although more research is needed to further guide clinical decision-making.

The FDA has approved Ilumya (tildrakizumab-asmn) for active psoriatic arthritis in adults based on findings from the phase 3 INSPIRE-1 and INSPIRE-2 trials.

For patients with stage 3 CKD, fruits and vegetables were associated with better clinical outcomes than standard treatment or usual care.

Parents and caregivers should stop serving Once Upon a Farm Tractor Wheels toddler bars right away because they could cause deadly choking.

Dr Waldman discussed social media as a patient education tool, the unforeseen benefits on clinical practice by using TikTok, ...

Patients with psoriasis with obesity are at an increased risk for primary failure of biologic therapies when compared with those without obesity.

Ivarmacitinib use for 52 weeks in adolescents and adults with AD was associated with skin clearance, symptom relief, and quality of life improvements.

Apremilast is effective for the treatment of patients with plaque psoriasis who have limited skin involvement, including in high-impact areas.

Maternal AD is associated with increased risk for some obstetric and neonatal adverse events, such as pre-eclampsia and Staphylococcal septicemia.

The quadrivalent HPV vaccine provides durable immune responses and protects against cervical disease in women with HIV.